Trametinib, dabrafenib strike at BRAF-mutant disease: Commentary

Jeffrey A. Sosman*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalOncology Report
Issue numberJULY
StatePublished - Jul 1 2012

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this